Introduction
Abdominal pain and tenderness are common features of diabetic ketoacidosis (Beardwood, 1935) . This pain has been variously attributed to gastric distension (Malins, 1968) , stretching of the hepatic capsule (Warren and LeCompte, 1952) , and inflammation of the pancreas (Tully and Lowenthal, 1958; Hughes, 1961) . Usually it subsides rapidly with treatment of the metabolic derangements. Where pain and tenderness persist beyond the first few hours of therapy, however, the possibility of an acute surgical or additional medical condition precipitating or complicating the metabolic disturbance must be considered. In such circumstances measurement of the serum amylase would invariably be made before surgery.
Finn and Cope (1963) observed a rise in serum amylase in eight out of 1 cases of diabetic coma. Death occurred whenever the serum amylase exceeded 900 units, but at necropsy no evidence of acute pancreatitis was found. Tully and Lowenthal (1958) , on the other hand, stated that whenever the serum amylase is raised in diabetic coma pancreatic inflammation is present. There is, therefore, conflicting opinion on the significance of a raised serum amylase level in diabetic ketoacidosis. The present study was devised to analyse the frequency of hyperamylasaemia in this condition and to determine the relation to concurrent clinical and biochemical features.
Patients and Methods Thirty-five consecutive episodes of diabetic ketoacidosis were studied. Patients were included if on admission they had hyperglycaemia, heavy ketonuria, and a serum bicarbonate of <18 mEq/l. Only four cases (4a, 8, 13 , and 27) were unable to respond to stimuli. Twenty-nine patients were studied. Three (cases 4, 17, and 19) were admitted with one further episode and one (case 11) with three further episodes, and these were included again in the study.
Venous blood -samples were taken on admission and at approximately 3, 6, 12, 18, 24, 30, 36, 48, 60, 72, and Method according to Shihabi and Bishop (1971) , upper normal limit 22 units (absorbance change per min x 10').
ONSET OF ILLNESS
In 13 instances the onset was very acute (less than 48 hours) and serum anylase was raised in 10 of these episodes (77%). In 22 the onset was more insidious and the serum amylase was raised in only 11 (50%). This contrasts with Finn and Cope (1963) who observed that an insidious onset was most often associated with hyperamylasaemia.
SEVERITY OF METABOLIC DERANGEMENT
In 18 episodes the blood sugar on admission was 500 mg/100 ml or less. Serum amylase was raised in only seven of these (39%), in contrast to 14 in the 17 remaining episodes (82%). Severe initial hyperglycaemia may explain the higher incidence of hyperamylasaemia reported by Finn and Cope (1963) , since all their cases, by selection, had an initial blood sugar greater than 600 mg/100 ml. Reid and Myers (1932) stated that raised levels of serum amylase in patients not receiving insulin bore a relation to the blood sugar level.
Pancreatitis has been recorded in association with other conditions causing metabolic acidosis (Bennett et al., 1953; Tranquada et al., 1966) . In the present study, however, no correlation was found between hyperamylasaemia and the degree of acidosis (r = 0-055). Taking as criteria for hepatic involvement the raising of at least two relevant enzyme levels in the same sample or of one enzyme in two consecutive samples, this was independent of hyperamylasaemia in our subjects. The above criteria were met in five of 12 episodes without hyperamylasaemia (42%), in eight of 14 episodes with peak amylase between 200 and 1,000 units (57%), and in one of five episodes where the peak amylase exceeded 1,000 units (20%).
MORBIDITY AND MORTALITY
No delay in clinical recovery was noted in patients with raised amylase levels. All patients with gross rises survived. Four (cases 10, 12, 25, and 28) died during the acute episode of ketoacidosis. All had severe impairment of renal function, congestive cardiac failure, and pneumonia. One (case 10) had also been slightly jaundiced and the peak amylase was 530 units. Necropsy showed stones in the gall bladder, but no evidence of obstruction to the biliary tract, and the pancreas was normal. Necropsy in case 28, where the serum amylase had not been raised, showed cystic changes throughout the pancreas but no evidence of acute pancreatitis. Permission for necropsy was not obtained in cases 12 (peak amylase 400 units) and 25 (amylase normal).
ABDOMINAL PAIN-INCIDENCE AND FEATURES
Abdominal pain was present in 18 episodes (51%). It was often upper abdominal but was usually poorly localized. There was no correlation between the presence of abdominal pain and tenderness on the one hand and hyperamylasaemia on the other. The highest recorded amylase in this study (5,333 units) occurred in a patient who had no abdominal symptoms whatever (case 1). In other cases pain and tenderness occurred without hyperamylasaemia. Other features suggesting acute pancreatitis such as severe back pain, abdominal rigidity, and cyanosis were not found in any patientt.
In 13 episodes objective evidence was obtained for a concurrent illness or precipitating factor which might of itself have caused abdominal pain. These are listed in table I (cases 3, 10, 12, 17a, 17b, 19a, 19b, 20, 22, and 24-27) . The actual incidence of abdominal pain or tenderness in this group was 69% with a similar incidence of 63% (14 out of 22 episodes) in the rema ning patients. The fact that the most frequent localization of pain and tenderness was to the right upper quadrant supports the suggestion that the liver capsule is being stretched (Warren and LeCompte, 1952) .
Evidence for gastric distension was sought on plain abdominal x-ray pictures taken on admission in 13 episodes and was noted in three subjects, all of whom had abdominal pain. Since there were eight who experienced abdominal pain despite failure to show gastric distension, this was a factor in only a minority of our subjects.
ORIGIN OF HYPERAMYLASAEMIA
Amylase isoenzyme studies were not carried out since recent experience has shown that they do not adequately characterize the tissue of origin (Rajasinghan et al., 1971) .
In considering the origin and significance of the hyperamylasaemia, the possibility of acute pancreatitis arises. Abdominal pain and tenderness, however, were not consistently associated with hyperamylasaemia and the other features of acute pancreatitis were notably absent. Since acute pancreatitis itselfcarries a mortality of between 10 and 25% (Jones, 1955; Pollock, 1959; Trapnell, 1966) , it would be reasonable to expect a high mortality in diabetic ketoacidosis with hyperamylasaemia if the latter was indicative of acute pancreatitis. Where diabetic ketoacidosis has undoubtedly been associated with acute pancreatitis the mortality has been very high (Hughes, 1961; Bossak and Joelson, 1956 ). Such increased mortality was not seen in the present series. In our study, the minimal rise of serum lipase levels, when estimated, suggests that acute pancreatitis is not the cause of the hyperamylasaemia, though transient leakage of enzyme from the pancreas without significant cell necrosis seems quite possible, and it is difficult to envisage an alternative source in view of the extent of this elevation which not uncommonly overlaps the range encountered in acute haemorrhagic pancreatitis.
now used almost exclusively in the management of patients with hypothyroidism. The dose recommended by the major textbooks of medicine (Selenkow and Ingbar, 1970; Stanbury, 1967; Strong, 1968) and endocrinology (Ingbar and Woeber, 1967; Hall et al., 1969; Means et al., 1963) lies between 0-2 mg and 0 4 mg daily, and there is general agreement that 0 3 mg daily is the average replacement dose. It is well known that the serum thyroxine concentration is raised on this dose and in the past it has been assumed that since the patient was receiving only T-4, and no replacement with the metabolically more potent triiodo-L-thyronine (T-3), that this was essential to maintain the euthyroid state (Ingbar and Woeber, 1968 shown that there is considerable extrathyroidal conversion of T-4 to T-3 (Pittman et al., 1971; Sterling et al., 1970) and that raised serum T-3 levels are found in athyreotic subjects receiving T-4 only (Braverman et al., 1970) . These findings raise the possibility that many subjects on replacement therapy with T-4 are mildly hyperthyroid but this state escapes detection in view of the insensitive methods available for the clinical assessment of thyroid status (Larsen, 1972) . Goolden and his colleagues (1971) provided some support for this view by showing that the red cell sodium concentration which is increased in hyperthyroidism is also raised in subjects receiving 0 3 mg T-4 daily. The availability of a wide range of precise diagnostic techniques has made it possible to test this hypothesis and to study the thyroid hormone requirements of a group of unselected patients with hypothyroidism.
Patients, Materials, and Methods Twenty-two consecutive patients with untreated symptomatic hypothyroidi3m attending an endocrine clinic were studied. The diagnosis of symptomatic hypothyroidism was accepted in all patients who presented with symptoms consistent with hypothyroidism and were found to have a raised serum TSH concentration (Evered et al., 1973) . Seventeen of the patients had developed hypothyroidism spontaneously, three after 131I therapy and two after partial thyroidectomy for hyperthyroidism. None of the subjects had overt ischaemic heart disease.
